# Testosterone Therapy for ED: When It Helps and When It Does Not

> Testosterone is heavily marketed as the answer to erectile dysfunction. It is the right treatment for a specific, testable group of men — and the wrong one, with real consequences, for everyone else.

- **Source:** ED Treatment Guides (https://www.edtreatmentguides.com/treatments/testosterone-therapy)
- **Last updated:** 2025-11-18
- **Type:** treatment
- **Category:** Hormonal
- **Prescription:** Prescription only
- **Evidence:** Moderate evidence
- **Onset:** 3–6 weeks for libido; up to 6 months for erectile function
- **Duration:** Ongoing while treatment continues
- **Typical US cash cost:** $20–$150 per month depending on formulation, plus monitoring bloodwork
- **Best for:** Men with symptoms plus two confirmed low morning testosterone results; Men with low libido alongside erectile difficulty; Men whose ED responds poorly to PDE5 inhibitors and who are also hypogonadal
- **Not for:** Men with normal testosterone levels; Men who want to father a child in the near future; Men with untreated prostate or breast cancer, or severe untreated sleep apnoea
- **Common side effects:** Thickened blood (raised haematocrit); Acne and oily skin; Reduced sperm production and fertility; Testicular shrinkage; Fluid retention; Worsening of sleep apnoea

## Key points

- Testosterone treats low testosterone. It is not a general ED treatment, and it does not reliably help men whose levels are normal.
- Diagnosis requires **two separate morning blood tests**, taken fasting, on different days — a single low result is not enough.
- Its clearest effect is on libido and energy. Its effect on erections alone is more modest, and it is often combined with a PDE5 inhibitor.
- It suppresses sperm production. If you may want children, say so before you start — there are alternatives that preserve fertility.
- Anyone on testosterone needs ongoing monitoring of haematocrit, PSA where appropriate, and symptoms.

## Who it actually helps

Low testosterone and erectile dysfunction overlap, but they are not the same condition and they do not respond to the same treatment. Testosterone drives sexual **desire** far more strongly than it drives the mechanics of an erection. That distinction explains most of the confusion in this area.

**Matching the symptom to the treatment**

| Presentation | What usually helps |
| --- | --- |
| Good desire, poor erection | PDE5 inhibitor and investigation of vascular causes. Testosterone is unlikely to be the answer. |
| Low desire, low energy, poor morning erections, confirmed low testosterone | Testosterone therapy is a reasonable first step, often alongside a PDE5 inhibitor. |
| Poor response to PDE5 inhibitors plus confirmed low testosterone | Correcting testosterone can improve the response to the tablet — a well-described interaction. |
| Any symptoms with normal testosterone | Testosterone therapy is not indicated. Look elsewhere for the cause. |

## Getting the diagnosis right

Testosterone follows a daily rhythm, peaking in the morning, and a single reading can be misleading. Guidelines therefore require confirmation.

1. **Two morning total testosterone measurements** on separate days, ideally before 10am and fasting. A commonly used threshold for deficiency is around 300 ng/dL, though laboratories and guidelines differ.
2. **Symptoms that match** — low libido, fatigue, loss of morning erections, low mood, reduced muscle mass. Numbers without symptoms do not warrant treatment.
3. **Follow-up tests to find the cause** — LH and FSH to distinguish a testicular problem from a pituitary one, plus prolactin where indicated.
4. **Baseline safety bloods** — haematocrit and, in men over 40 or with risk factors, PSA.
5. **A fertility conversation** before anything is prescribed.

> **Be cautious with 'low T' clinics**
>
> Clinics whose revenue depends on prescribing testosterone have an obvious incentive to interpret borderline results generously. If a clinic prescribes on one afternoon blood test, without LH, without a fertility discussion and without a monitoring plan, that is a red flag.

## The available formulations

| Form | Frequency | Considerations |
| --- | --- | --- |
| Intramuscular or subcutaneous injection | Weekly to fortnightly | Inexpensive and effective. Levels can peak and trough; more frequent smaller doses smooth this out. |
| Topical gel | Daily | Steady levels, but the drug can transfer to a partner or child through skin contact. Cover the site. |
| Skin patch | Daily | Steady levels; skin irritation is common. |
| Subcutaneous pellets | Every 3–6 months | Convenient. Requires a minor procedure and cannot be adjusted or withdrawn quickly. |
| Nasal gel | Multiple times daily | Avoids skin transfer; the dosing schedule suits few people. |
| Oral testosterone undecanoate | Twice daily with food | Newer formulations avoid the liver toxicity of older oral androgens. Blood pressure monitoring is required. |

> **Skin transfer is a real hazard**
>
> Testosterone gel transferred from a man's skin to a child has caused premature virilisation. Wash your hands, cover the application site with clothing, and keep the area away from children and partners until it is washed.

## Risks and monitoring

- **Fertility suppression** — Exogenous testosterone shuts down the body's own signal to the testicles, and sperm production falls — sometimes to zero. This is the single most important consequence to understand before starting. It is usually reversible, but not always, and recovery can take many months.
- **Raised haematocrit** — Testosterone stimulates red cell production. Too thick a blood count raises clotting risk, so haematocrit is checked at baseline, at 3–6 months, then annually.
- **Prostate effects** — Testosterone does not appear to cause prostate cancer, but it can accelerate an existing one. PSA monitoring is standard in men over 40 or with risk factors, and untreated prostate cancer is a contraindication.
- **Cardiovascular safety** — This was debated for years. The large randomised TRAVERSE trial, published in 2023, did not find an increase in major adverse cardiac events among men with hypogonadism and elevated cardiovascular risk. Some formulations still carry blood-pressure warnings, and monitoring remains appropriate.
- **Sleep apnoea** — Testosterone can worsen existing obstructive sleep apnoea. If you snore heavily or wake unrefreshed, get assessed first — see [sleep apnoea and ED](https://www.edtreatmentguides.com/causes/sleep-apnea).

> **If you want to preserve fertility**
>
> Tell your clinician. Alternatives that raise your own testosterone production rather than replacing it — such as hCG or clomiphene, both used off-label for this purpose — can be appropriate, and testosterone can sometimes be combined with hCG to protect sperm production.

## Frequently asked questions

### Will testosterone fix my ED?

Only if low testosterone is contributing to it. In men with normal levels it does not improve erections, and it carries real risks. Confirm the diagnosis before treating it.

### How long before I notice anything?

Libido and mood often respond within three to six weeks. Erectile function, if it responds at all, can take up to six months.

### Can I take testosterone and Viagra together?

Yes, and in hypogonadal men the combination often works better than either alone. Both should be prescribed and monitored by the same clinician.

### Is it lifelong?

Usually, if the cause is permanent. Stopping returns you to your untreated baseline — and after suppression, sometimes temporarily below it.

### Do over-the-counter testosterone boosters work?

There is no good evidence that supplement 'boosters' raise testosterone meaningfully or improve erections. See our [review of ED supplements](https://www.edtreatmentguides.com/treatments/supplements).

## Sources

- American Urological Association. [Testosterone Deficiency: AUA Guideline](https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline) (2018)
- Endocrine Society. [Testosterone Therapy in Men With Hypogonadism — clinical practice guideline](https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy) (2018)
- U.S. Food and Drug Administration. [Drugs@FDA — approved drug products and prescribing information](https://www.accessdata.fda.gov/scripts/cder/daf/)
- National Institute of Diabetes and Digestive and Kidney Diseases. [Treatment for Erectile Dysfunction](https://www.niddk.nih.gov/health-information/urologic-diseases/erectile-dysfunction/treatment)

## Related pages

- [Low Testosterone and ED: Sorting Signal From Marketing](https://www.edtreatmentguides.com/causes/low-testosterone)
- [Sildenafil (Viagra): How It Works, Dosing, Cost and Side Effects](https://www.edtreatmentguides.com/treatments/sildenafil)
- [Sleep Apnoea, Poor Sleep and ED](https://www.edtreatmentguides.com/causes/sleep-apnea)
- [ED Supplements and 'Male Enhancement': An Evidence Review](https://www.edtreatmentguides.com/treatments/supplements)

---

_This page is general health information, not medical advice. It cannot account for your own history, medications or risk factors. Talk to a licensed clinician before starting, stopping or changing any treatment._

_Canonical URL: https://www.edtreatmentguides.com/treatments/testosterone-therapy — HTML for people, Markdown for agents._